Xiao Chen

Title: Innovations of Inventor Xiao Chen

Introduction

Xiao Chen is a notable inventor based in Province, China. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing recombinant antibodies. His innovative approach has the potential to enhance industrial production processes in the pharmaceutical industry.

Latest Patents

Xiao Chen holds a patent titled "Method for obtaining high-yield, stable expression cell clones and antibody molecules obtained thereby." This patent describes a method for obtaining high-yield, stable expression cell clones from myeloma cell lines in a protein-free culture medium. The method is designed for the industrial production of recombinant antibodies and consists of three stages: adapting to a protein-free culture medium, culturing cells at low density, and screening high-yield, stable expression cell clones. This innovative technique can be utilized to produce a humanized anti-NeuGcGM3 14F7 recombinant antibody.

Career Highlights

Throughout his career, Xiao Chen has worked with various organizations, including Biotech Pharmaceutical Co. Ltd. and Centro De Inmunologia Molecular. His experience in these companies has allowed him to refine his skills and contribute to advancements in biotechnology.

Collaborations

Xiao Chen has collaborated with several professionals in his field, including MeyLen Chea and Julio Palacios. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Xiao Chen's contributions to biotechnology, particularly through his patented methods for producing recombinant antibodies, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future advancements in the field.